Pulmonary Drugs Market By Drugs Class (Corticosteroids, Long Acting Beta-2 Agonists, Antihistamines, Vasodilators, Short Acting Beta-2 Agonists, and Others), By Application (Asthma & COPD, Allergic Rhinitis, Pulmonary Arterial Hypertension, Cystic Fibrosis, and Others), By Distribution Channel (Retail Pharmacies, Online Pharmacies and Hospitals Pharmacies), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2029

Report Code: PMI10618 | Publish Date: March 2024 | No. of Pages: 179

Global Pulmonary Drugs Market By Overview

Pulmonary drugs are the medications which are indicated for the treatment of various types of pulmonary disease such as asthma, pneumonia, allergic rhinitis, pulmonary hypertension, and others. Pulmonary drugs are available in various dosages from such as oral tablets, oral liquids, and injections or inhalations.

Thelaunches and approval of novel drugs indicated for the treatment of pulmonary disease is also expected to drive the market growth over forecast period. For instance in 2017, AstraZeneca Plc. received U.S. Food and Drug Administration (FDA) approval for its drugsFasenra (benralizumab) findicated for the treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype.

Furthermore, high prevalence of chronic pulmonary disease such as chronic obstructive pulmonary disease and asthma is also expected to drastically increase demand for pulmonary drugs and drive its market growth. For instance, according to the World Health Organization estimates chronic obstructive pulmonary disease (COPD) affects around 65 million people globally and around yearly around 3 million people died of COPD.

The pulmonary drugs market has been segmented on the basis of drug class, application, distribution channel, and region.

The drug class segment includes Inhaled Corticosteroids, Long Acting Beta-2 Agonists, Antihistamines, Vasodilators, Short Acting Beta-2 Agonists, and others.

On the basis of application, asthma & copd, allergic rhinitis, pulmonary arterial hypertension

cystic fibrosis, and others.

On the basis of distribution channel, the pulmonary drugs market has been segmented in retail pharmacies, online pharmacies and hospitals pharmacies.

On the basis of region, the target market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East, and Africa. North America is expected to account major market share as compared to that of other regions.

Key players operating in the pulmonary drugs Market includes, AstraZenca Plc., Sanofi SA, GlaxoSmithKline Plc.,Meda Pharmaceuticals,Cheisifarmaceutici S.p.A., Circassia Pharmaceuticals Plc., Mallinckrodt Pharmaceuticals Plc., Zambon Company S.p.A., Alaxia SAS, and Merck Sharp & Dohme Limited.

Global Pulmonary Drugs Market By Table of Contents

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Preview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Drugs Class
      • Market Snippet, By Application
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Region
    • Opportunity Map Analysis
  3. Market Dynamics Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
      • Drivers- Restraints Impact Analysis
      • PEST Analysis
      • Porter’s Five Forces Analysis
  4. Market Segmentation, By Drugs Class, 2018 – 2028, (US$ Mn)
    • Introduction
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
      • Y-o-Y Growth Analysis (%), 2019 – 2028
      • Segment Trends
    • Inhaled Corticosteroids
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Long Acting Beta-2 Agonists
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Antihistamines
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Vasodilators
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Short Acting Beta-2 Agonists
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Others
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
  5. Market Segmentation, Application, 2018 – 2028, (US$ Mn)
    • Introduction
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
      • Y-o-Y Growth Analysis (%), 2019 – 2028
      • Segment Trends
    • Asthma & COPD
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Allergic Rhinitis
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Pulmonary Arterial Hypertension
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Cystic Fibrosis
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Others
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
  6. Market Segmentation, By Distribution Channel, 2018 – 2028, (US$ Mn)
    • Introduction
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
      • Y-o-Y Growth Analysis (%), 2019 – 2028
      • Segment Trends
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
    • Hospitals
      • Introduction
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
  7. Global Market, By Region, 2018 – 2028, (US$ Mn)
    • Introduction
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
      • Y-o-Y Growth Analysis (%), 2019 – 2028
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Drugs Class, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Application, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Distribution Channels, 2018 – 2028
      • Market Size and Forecast (US$ Mn), By Country, 2016 – 20262018 – 2028

Ø  U.S.

Ø  Canada

  • Latin America
    • Market Size and Forecast (US$ Mn), By Drugs Class, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Application, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Distribution Channels, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Country, 2016 – 20262018 – 2028

Ø  Brazil

Ø  Mexico

Ø  Argentina and Chile   

Ø  Rest of Latin America

  • Europe
    • Market Size and Forecast (US$ Mn), By Drugs Class, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Application, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Distribution Channels, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Country, 2016 – 20262018 – 2028

Ø  Germany

Ø  UK

Ø  France

Ø  Russia

Ø  Italy

Ø  Switzerland

Ø  Sweden

Ø  Rest of Europe           

  • Asia Pacific
    • Market Size and Forecast (US$ Mn), By Drugs Class, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Application, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Distribution Channels, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Country, 2016 – 20262018 – 2028

Ø  China

Ø  India

Ø  Australia & New Zealand

Ø  Japan

Ø  South Korea

Ø  Rest of Asia Pacific

  • Middle East
    • Market Size and Forecast (US$ Mn), By Drugs Class, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Application, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Distribution Channels, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Country, 2016 – 20262018 – 2028

Ø  GCC

Ø  Israel

Ø  Saudi Arabia

Ø  UAE

Ø  Rest of Middle East

  • Africa
    • Market Size and Forecast (US$ Mn), By Drugs Class, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Application, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Distribution Channels, 2018 – 2028
    • Market Size and Forecast (US$ Mn), By Country, 2016 – 20262018 – 2028

Ø  North Africa

Ø  Central Africa

Ø  South Africa

  1. Competitive Landscape
    • Heat Map Analysis
    • Company Profiles
      • AstraZenca Plc.

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

  • Sanofi SA

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

  • GlaxoSmithKline Plc.

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

  • Meda Pharmaceuticals

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

  • Cheisifarmaceutici S.p.A.

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

  • Circassia Pharmaceuticals Plc.

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

  • Mallinckrodt Pharmaceuticals Plc.

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

  • Zambon Company S.p.A.

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

  • Alaxia SAS

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

  • Merck Sharp & Dohme Limited.

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

  • Merck & Co AG

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

  • Teva Pharmaceutical Industries Ltd.

Ø  Company Overview

Ø  Product Portfolio

Ø  Key Highlights

Ø  Financial Overview

Ø  Business Strategy Overview

  • Analyst Views
  1. Section
    • Research Methodology
    • About Us
    • Contact

FAQs

The pulmonary drugs market has been segmented on the basis of drug class, application, distribution channel, and region.

High prevalence of chronic pulmonary disease such as chronic obstructive pulmonary disease and asthma is also expected to drastically increase demand for pulmonary drugs and drive its market growth.

High cost of drugs might hampers the market

Key players operating in the pulmonary drugs Market includes, AstraZenca Plc., Sanofi SA, GlaxoSmithKline Plc.,Meda Pharmaceuticals, Cheisifarmaceutici S.p.A., Circassia Pharmaceuticals Plc., Mallinckrodt Pharmaceuticals Plc., Zambon Company S.p.A., Alaxia SAS, and Merck Sharp & Dohme Limited.

North America is expected to account major market share as compared to that of other regions.